Primary staging and follow-up of high risk melanoma patients with whole-body18F-fluorodeoxyglucose positron emission tomography
Open Access
- 1 March 1999
- Vol. 85 (5) , 1199-1200
- https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1199::aid-cncr28>3.0.co;2-1
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Primary staging and follow-up of high risk melanoma patients with whole-body18F-fluorodeoxyglucose positron emission tomographyCancer, 1998
- Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.Journal of Clinical Oncology, 1998
- Sentinel Node Biopsy in Melanoma Patients: Dynamic Lymphoscintigraphy Followed by Intraoperative Gamma Probe and Vital Dye GuidanceWorld Journal of Surgery, 1997
- Tumor thickness as a guide to surgical management of clinical stage I melanoma patientsCancer, 1979